Global Recombinant Human Follicle-stimulating Hormone Market Research Report 2023

The global Recombinant Human Follicle-stimulating Hormone market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Recombinant Human Follicle-stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Recombinant Human Follicle-stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Recombinant Human Follicle-stimulating Hormone in Infertility Treatment is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Recombinant Human Follicle-stimulating Hormone include Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL and Scripps Laboratories, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Follicle-stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Follicle-stimulating Hormone.

The Recombinant Human Follicle-stimulating Hormone market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Recombinant Human Follicle-stimulating Hormone market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Follicle-stimulating Hormone companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 75IU

1.2.3 150IU

1.2.4 Others

1.3 Market by Application

1.3.1 Global Recombinant Human Follicle-stimulating Hormone Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Infertility Treatment

1.3.3 Assisted Reproductive Technology

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Recombinant Human Follicle-stimulating Hormone Market Perspective (2018-2029)

2.2 Recombinant Human Follicle-stimulating Hormone Growth Trends by Region

2.2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Recombinant Human Follicle-stimulating Hormone Historic Market Size by Region (2018-2023)

2.2.3 Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2024-2029)

2.3 Recombinant Human Follicle-stimulating Hormone Market Dynamics

2.3.1 Recombinant Human Follicle-stimulating Hormone Industry Trends

2.3.2 Recombinant Human Follicle-stimulating Hormone Market Drivers

2.3.3 Recombinant Human Follicle-stimulating Hormone Market Challenges

2.3.4 Recombinant Human Follicle-stimulating Hormone Market Restraints

3.1 Global Top Recombinant Human Follicle-stimulating Hormone Players by Revenue

3.1.1 Global Top Recombinant Human Follicle-stimulating Hormone Players by Revenue (2018-2023)

3.1.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Players (2018-2023)

3.2 Global Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Recombinant Human Follicle-stimulating Hormone Revenue

3.4 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio

3.4.1 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human Follicle-stimulating Hormone Revenue in 2022

3.5 Recombinant Human Follicle-stimulating Hormone Key Players Head office and Area Served

3.6 Key Players Recombinant Human Follicle-stimulating Hormone Product Solution and Service

3.7 Date of Enter into Recombinant Human Follicle-stimulating Hormone Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Type (2018-2023)

4.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2024-2029)

5.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Application (2018-2023)

5.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2024-2029)

6.1 North America Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)

6.2 North America Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023)

6.4 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)

7.2 Europe Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023)

7.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)

8.2 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2018-2023)

8.4 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)

9.2 Latin America Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023)

9.4 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size (2018-2029)

10.2 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023)

10.4 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck Recombinant Human Follicle-stimulating Hormone Introduction

11.1.4 Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.1.5 Merck Recent Development

11.2 Ferring

11.2.1 Ferring Company Detail

11.2.2 Ferring Business Overview

11.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Introduction

11.2.4 Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.2.5 Ferring Recent Development

11.3 Livzon

11.3.1 Livzon Company Detail

11.3.2 Livzon Business Overview

11.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Introduction

11.3.4 Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.3.5 Livzon Recent Development

11.4 Gedeon Richter

11.4.1 Gedeon Richter Company Detail

11.4.2 Gedeon Richter Business Overview

11.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Introduction

11.4.4 Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.4.5 Gedeon Richter Recent Development

11.5 GenSci

11.5.1 GenSci Company Detail

11.5.2 GenSci Business Overview

11.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Introduction

11.5.4 GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.5.5 GenSci Recent Development

11.6 Teva

11.6.1 Teva Company Detail

11.6.2 Teva Business Overview

11.6.3 Teva Recombinant Human Follicle-stimulating Hormone Introduction

11.6.4 Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.6.5 Teva Recent Development

11.7 ChangChun High & New Technology

11.7.1 ChangChun High & New Technology Company Detail

11.7.2 ChangChun High & New Technology Business Overview

11.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Introduction

11.7.4 ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.7.5 ChangChun High & New Technology Recent Development

11.8 ABL

11.8.1 ABL Company Detail

11.8.2 ABL Business Overview

11.8.3 ABL Recombinant Human Follicle-stimulating Hormone Introduction

11.8.4 ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.8.5 ABL Recent Development

11.9 Scripps Laboratories

11.9.1 Scripps Laboratories Company Detail

11.9.2 Scripps Laboratories Business Overview

11.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Introduction

11.9.4 Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.9.5 Scripps Laboratories Recent Development

11.10 Alphamab Oncology

11.10.1 Alphamab Oncology Company Detail

11.10.2 Alphamab Oncology Business Overview

11.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Introduction

11.10.4 Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.10.5 Alphamab Oncology Recent Development

11.11 Hunan Jingfeng Pharmaceutical

11.11.1 Hunan Jingfeng Pharmaceutical Company Detail

11.11.2 Hunan Jingfeng Pharmaceutical Business Overview

11.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.11.4 Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.11.5 Hunan Jingfeng Pharmaceutical Recent Development

11.12 Qilu Pharmaceutical

11.12.1 Qilu Pharmaceutical Company Detail

11.12.2 Qilu Pharmaceutical Business Overview

11.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.12.4 Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.12.5 Qilu Pharmaceutical Recent Development

11.13 Beijing SL Pharmaceutical

11.13.1 Beijing SL Pharmaceutical Company Detail

11.13.2 Beijing SL Pharmaceutical Business Overview

11.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.13.4 Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

11.13.5 Beijing SL Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of 75IU

    Table 3. Key Players of 150IU

    Table 4. Key Players of Others

    Table 5. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2018-2023)

    Table 9. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2024-2029)

    Table 11. Recombinant Human Follicle-stimulating Hormone Market Trends

    Table 12. Recombinant Human Follicle-stimulating Hormone Market Drivers

    Table 13. Recombinant Human Follicle-stimulating Hormone Market Challenges

    Table 14. Recombinant Human Follicle-stimulating Hormone Market Restraints

    Table 15. Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players (2018-2023)

    Table 17. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2022)

    Table 18. Ranking of Global Top Recombinant Human Follicle-stimulating Hormone Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Recombinant Human Follicle-stimulating Hormone Product Solution and Service

    Table 22. Date of Enter into Recombinant Human Follicle-stimulating Hormone Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2018-2023)

    Table 26. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2024-2029)

    Table 28. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2018-2023)

    Table 30. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2024-2029)

    Table 32. North America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Merck Company Detail

    Table 48. Merck Business Overview

    Table 49. Merck Recombinant Human Follicle-stimulating Hormone Product

    Table 50. Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 51. Merck Recent Development

    Table 52. Ferring Company Detail

    Table 53. Ferring Business Overview

    Table 54. Ferring Recombinant Human Follicle-stimulating Hormone Product

    Table 55. Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 56. Ferring Recent Development

    Table 57. Livzon Company Detail

    Table 58. Livzon Business Overview

    Table 59. Livzon Recombinant Human Follicle-stimulating Hormone Product

    Table 60. Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 61. Livzon Recent Development

    Table 62. Gedeon Richter Company Detail

    Table 63. Gedeon Richter Business Overview

    Table 64. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product

    Table 65. Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 66. Gedeon Richter Recent Development

    Table 67. GenSci Company Detail

    Table 68. GenSci Business Overview

    Table 69. GenSci Recombinant Human Follicle-stimulating Hormone Product

    Table 70. GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 71. GenSci Recent Development

    Table 72. Teva Company Detail

    Table 73. Teva Business Overview

    Table 74. Teva Recombinant Human Follicle-stimulating Hormone Product

    Table 75. Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 76. Teva Recent Development

    Table 77. ChangChun High & New Technology Company Detail

    Table 78. ChangChun High & New Technology Business Overview

    Table 79. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product

    Table 80. ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 81. ChangChun High & New Technology Recent Development

    Table 82. ABL Company Detail

    Table 83. ABL Business Overview

    Table 84. ABL Recombinant Human Follicle-stimulating Hormone Product

    Table 85. ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 86. ABL Recent Development

    Table 87. Scripps Laboratories Company Detail

    Table 88. Scripps Laboratories Business Overview

    Table 89. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product

    Table 90. Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 91. Scripps Laboratories Recent Development

    Table 92. Alphamab Oncology Company Detail

    Table 93. Alphamab Oncology Business Overview

    Table 94. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product

    Table 95. Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 96. Alphamab Oncology Recent Development

    Table 97. Hunan Jingfeng Pharmaceutical Company Detail

    Table 98. Hunan Jingfeng Pharmaceutical Business Overview

    Table 99. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

    Table 100. Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 101. Hunan Jingfeng Pharmaceutical Recent Development

    Table 102. Qilu Pharmaceutical Company Detail

    Table 103. Qilu Pharmaceutical Business Overview

    Table 104. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

    Table 105. Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 106. Qilu Pharmaceutical Recent Development

    Table 107. Beijing SL Pharmaceutical Company Detail

    Table 108. Beijing SL Pharmaceutical Business Overview

    Table 109. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

    Table 110. Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2018-2023) & (US$ Million)

    Table 111. Beijing SL Pharmaceutical Recent Development

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Recombinant Human Follicle-stimulating Hormone Market Share by Type: 2022 VS 2029

    Figure 3. 75IU Features

    Figure 4. 150IU Features

    Figure 5. Others Features

    Figure 6. Global Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application: 2022 VS 2029

    Figure 8. Infertility Treatment Case Studies

    Figure 9. Assisted Reproductive Technology Case Studies

    Figure 10. Recombinant Human Follicle-stimulating Hormone Report Years Considered

    Figure 11. Global Recombinant Human Follicle-stimulating Hormone Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Recombinant Human Follicle-stimulating Hormone Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region: 2022 VS 2029

    Figure 14. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players in 2022

    Figure 15. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2022

    Figure 17. North America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2018-2029)

    Figure 19. United States Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Recombinant Human Follicle-stimulating Hormone Market Share by Country (2018-2029)

    Figure 23. Germany Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Share by Region (2018-2029)

    Figure 31. China Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2018-2029)

    Figure 39. Mexico Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Share by Country (2018-2029)

    Figure 43. Turkey Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Merck Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 46. Ferring Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 47. Livzon Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 48. Gedeon Richter Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 49. GenSci Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 50. Teva Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 51. ChangChun High & New Technology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 52. ABL Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 53. Scripps Laboratories Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 54. Alphamab Oncology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 55. Hunan Jingfeng Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 56. Qilu Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 57. Beijing SL Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed